January 20, 2012
Fitch Even Partner Kendrew H. Colton was quoted in an article published in the January 16 online and print editions of Chemical & Engineering News, a weekly publication of the American Chemical Society. The article, titled "Supreme Court Looks at Medical Patents," discusses the potential ramifications of the Court's upcoming decision in Mayo v. Prometheus. This decision is expected to have significant effects on the future of molecular diagnostics and the emerging field of personalized medicine, impacting the biotechnology and pharmaceutical industries.
Mr. Colton has extensive intellectual property counseling and litigation experience involving patent infringement, contract licensing disputes, copyrights, unfair competition, and trade secrets. His practice specialty is designing strategies to achieve market exclusivity and freedom to operate for clients in established and emerging chemical and biochemical technologies. He is a member of the Executive Committee of the Chemistry and the Law Division (CHAL) of the American Chemical Society.
- IP Alert | USPTO Releases Latest Guidance for Evaluating Subject Matter Eligibility Under 35 U.S.C. § 101January 11, 2019 Read more
- IP Alert | USPTO Releases Guidance for Examining Computer-Implemented Functional Claim Limitations for Compliance with 35 U.S.C. § 112January 11, 2019 Read more